ALX Oncology is prioritizing evorpacept development in combination with anti-cancer antibodies that directly induce antibody-dependent cellular phagocytosis (ADCP), the primary proposed mechanism of ...
ZDNET's key takeaways Google's October Gemini Drop includes upgrades to Gemini Canvas.Explain a topic or upload images for ...
The company tucked into its Q3 earnings report its announcement that Jason Warnick will step down as CFO in Q1 2026, but will ...
Net Income -- $71 million in net income for Q3 2025, equating to $1.42 per diluted share reported for Q3 2025. Adjusted Net ...
CAVA (NYSE: CAVA) reported Q3 2025 earnings after the close on Tuesday, delivering results that largely matched expectations ...
Ramp reports that expense management software automates spending tracking, enhances compliance, and improves financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback